Abstract:AbstractBackgroundStatins are widely prescribed cholesterol‐lowering drugs but have been shown to increase the risk of type 2 diabetes mellitus. However, the molecular mechanisms underlying the diabetogenic effect of statins are still not fully understood.MethodsThe effects of geranylgeranyl transferase I and II (GGTase I and II) inhibition on insulin‐stimulated glucose uptake and GLUT4 translocation, and the dependence of these effects on insulin signalling were investigated in skeletal muscle cells. The protective effects of geranylgeranyl pyrophosphate (GGPP) and its precursor geranylgeraniol (GGOH) on simvastatin‐induced insulin resistance were evaluated in vitro and in vivo. The effect of GGTase II inhibition in skeletal muscle on insulin sensitivity in vivo was confirmed by adeno‐associated virus serotype 9 (AAV9)‐mediated knockdown of the specific subunit of GGTase II, RABGGTA. The regulatory mechanisms of GGTase I on insulin signalling and GGTase II on insulin‐stimulated GLUT4 translocation were investigated by knockdown of RhoA, TAZ, IRS1, geranylgeranylation site mutation of RhoA, RAB8A, and RAB13.ResultsBoth inhibition of GGTase I and II mimicked simvastatin‐induced insulin resistance in skeletal muscle cells. GGPP and GGOH were able to prevent simvastatin‐induced skeletal muscle insulin resistance in vitro and in vivo. GGTase I inhibition suppressed the phosphorylation of AKT (Ser473) (−51.3%, P < 0.01), while GGTase II inhibition had no effect on it. AAV9‐mediated knockdown of RABGGTA in skeletal muscle impaired glucose disposal without disrupting insulin signalling in vivo (−46.2% for gastrocnemius glucose uptake, P < 0.001; −52.5% for tibialis anterior glucose uptake, P < 0.001; −17.8% for soleus glucose uptake, P < 0.05; −31.4% for extensor digitorum longus glucose uptake, P < 0.01). Inhibition of RhoA, TAZ, IRS1, or geranylgeranylation deficiency of RhoA attenuated the beneficial effect of GGPP on insulin signalling in skeletal muscle cells. Geranylgeranylation deficiency of RAB8A inhibited insulin‐stimulated GLUT4 translocation and concomitant glucose uptake in skeletal muscle cells (−42.8% for GLUT4 translocation, P < 0.01; −50.6% for glucose uptake, P < 0.001).ConclusionsGeranylgeranyl pyrophosphate regulates glucose uptake via GGTase I‐mediated insulin signalling‐dependent way and GGTase II‐mediated insulin signalling‐independent way in skeletal muscle. Supplementation of GGPP/GGOH could be a potential therapeutic strategy for statin‐induced insulin resistance.

The glucocorticoid-induced leucine zipper mediates statin-induced muscle damage

Resistance but not endurance training suppresses glucocorticoid-induced leucine zipper (GILZ) expression in human skeletal muscle

Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue

Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin

Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content

Regulation of Connexin Expression after Balloon Injury: Possible Mechanisms for Antiproliferative Effect of Statins.

Modeling statin-induced myopathy with human iPSCs reveals that impaired proteostasis underlies the myotoxicity and is targetable for the prevention

C2C12 myoblasts are more sensitive to the toxic effects of simvastatin than myotubes and show impaired proliferation and myotube formation

Excessive Expression Of Mir-1a By Statin Causes Skeletal Injury Through Targeting Mitogen-Activated Protein Kinase Kinase Kinase 1

Simvastatin Enhances Muscle Regeneration Through Autophagic Defect-Mediated Inflammation and mTOR Activation in G93ASOD1 Mice

The Role of Mitochondria in Statin-Induced Myopathy

Geranylgeranyl Pyrophosphate Depletion by Statins Compromises Skeletal Muscle Insulin Sensitivity

Statin-induced debilitating weakness and myopathy

[The Clinical and Muscular Pathological Features of Statin-Induced Myopathy].

SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis: Novel Mechanism of the Pleiotropic Effects of Statins

A glucocorticoid‐induced leucine‐zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells

Skeletal muscle fibre type-dependent effects of atorvastatin on the PI3K/Akt/mTOR signalling pathway and atrophy-related genes in rats

Abstract 650: Statins Modulate Rac-dependent IL-1 Beta Expression to Influence Calcium Composition

Statin uses and skeletal muscle-related phenotypes: insights from epidemiological and Mendelian randomization analyses

Statins Promote Interleukin-1β–Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol

[Role of Monocarboxylate Transporter in Statin-induced Cytotoxicity]